R R

What Is Ropinirole?

Ropinirole is a prescription non-ergot dopamine agonist used to treat Parkinson's disease and moderate to severe primary restless legs syndrome. It is available as immediate-release oral tablets, with extended-release formulations also available for Parkinson's disease. Ropinirole is the active ingredient associated with the brand name Requip. It activates dopamine receptors involved in movement regulation and other neurological functions. The immediate-release and extended-release formulations have different dosing schedules and should not be substituted without medical guidance. Ropinirole can improve symptoms but does not cure Parkinson's disease or restless legs syndrome. Important precautions include sudden sleep episodes, low blood pressure, and compulsive behaviors.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Ropinirole?

Ropinirole is a prescription non-ergot dopamine agonist used to treat Parkinson's disease and moderate to severe primary restless legs syndrome. It is available as immediate-release oral tablets, with extended-release formulations also available for Parkinson's disease. Ropinirole is the active ingredient associated with the brand name Requip. It activates dopamine receptors involved in movement regulation and other neurological functions. The immediate-release and extended-release formulations have different dosing schedules and should not be substituted without medical guidance. Ropinirole can improve symptoms but does not cure Parkinson's disease or restless legs syndrome. Important precautions include sudden sleep episodes, low blood pressure, and compulsive behaviors.

read more about ropinirole ...

Copy this HTML:

Copy HTML Copied!

How Does Ropinirole Work?

Ropinirole activates dopamine receptors, particularly receptors in the D2 family, including D3 receptors. Dopamine participates in pathways involved in movement, motivation, and other neurological functions. Parkinson's disease involves progressive loss of dopamine-producing nerve cells, contributing to tremor, stiffness, and slowed movement. Ropinirole compensates for part of this reduced dopamine signaling by directly stimulating receptors. In restless legs syndrome, dopamine receptor activation can reduce uncomfortable leg sensations and the urge to move during rest. The complete mechanism responsible for improvement in restless legs symptoms is not fully established. Dopamine stimulation can also influence sleep, perception, blood pressure, and impulse control.

What Conditions Does Ropinirole Treat?

Immediate-release ropinirole is approved for Parkinson's disease and moderate to severe primary restless legs syndrome in adults. Parkinson's disease causes progressive movement difficulties, including tremor, rigidity, and reduced movement speed. Restless legs syndrome causes uncomfortable leg sensations accompanied by an urge to move, usually worsening during rest or in the evening. Extended-release ropinirole formulations are approved for Parkinson's disease, not restless legs syndrome. Ropinirole may be used alone or with other Parkinson's medications when clinically appropriate. A neurologist evaluates symptoms, medical history, sleepiness, blood pressure, and other treatments before prescribing it. Ropinirole does not treat every cause of leg discomfort.

How Should Ropinirole Be Taken?

Immediate-release ropinirole for Parkinson's disease commonly starts at 0.25 mg three times daily, with gradual weekly increases according to response and tolerability. The maximum recommended dose is 24 mg daily. For restless legs syndrome, treatment usually begins at 0.25 mg once daily, one to three hours before bedtime, with gradual increases to a maximum of 4 mg daily. Extended-release ropinirole for Parkinson's disease is generally taken once daily and has separate dosing instructions. Tablets may be taken with or without food. Patients receiving hemodialysis have lower maximum doses. Significant treatment interruptions may require retitration, and discontinuation should be managed gradually under medical supervision.

What Are the Side Effects and Warnings of Ropinirole?

Common adverse effects include nausea, dizziness, sleepiness, fatigue, headache, and swelling in the legs. Serious risks include sudden sleep episodes during ordinary activities, fainting, orthostatic hypotension, hallucinations, and impulse-control disorders involving gambling, spending, eating, or sexual behavior. Ropinirole can worsen involuntary movements in Parkinson's disease and cause augmentation of restless legs syndrome, where symptoms begin earlier or become more severe. Abrupt discontinuation can produce withdrawal symptoms, including anxiety, depression, pain, and sweating. Patients should report severe sleepiness, new compulsive behaviors, hallucinations, or worsening movement symptoms. Driving may be unsafe when reduced alertness occurs.

Common Questions About Ropinirole

Is ropinirole the same as Requip?

Yes. Requip is a brand name associated with ropinirole, a dopamine agonist used for Parkinson's disease and restless legs syndrome.

Can ropinirole treat restless legs syndrome?

Yes. Immediate-release ropinirole is approved for moderate to severe primary restless legs syndrome in adults.

Can ropinirole cause sudden sleep episodes?

Yes. Ropinirole can cause patients to fall asleep during everyday activities, sometimes without noticeable warning signs.

Are immediate-release and extended-release ropinirole interchangeable?

No. The formulations have different dosing schedules and approved uses. Any conversion should follow a clinician's instructions.

References

DailyMed - ROPINIROLE tablet, film coated. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=85971b31-6f7d-421c-bf3c-5b33f3c1e781. Date Accessed November 4, 2026.

Ropinirole. LiverTox. https://www.ncbi.nlm.nih.gov/books/NBK548175/. Date Accessed November 4, 2026.

Ropinirole. MedlinePlus. https://medlineplus.gov/druginfo/meds/a698013.html. Date Accessed November 4, 2026.

Ropinirole. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Ropinirole. Date Accessed November 4, 2026.

Ropinirole. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK554532/. Date Accessed November 4, 2026.